NCT00440687View on ClinicalTrials.gov

Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care

PHASE4CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

March 31, 2004

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Fluticasone 500mcg BD via accuhaler or identical placebo

Trial Locations (1)

E1 2AT

Centre for Health Sciences, Queen Mary's School of Medicine and Dentistry, Barts and The London, 2 Newark Street,., London and Essex

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

British Lung Foundation

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

Queen Mary University of London

OTHER